Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|3|1|9-34

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.3, Iss.1, 2005-01, pp. : 9-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 239-250

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 1, 2009-01 ,pp. : 83-98

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia

By  

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 540-550

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Metabotropic Glutamate Receptor Modulators

By  

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 12-48

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 261-281

Bentham Science Publishers

Access to resources Recommend Favorite